Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 18, 2026 08:00 ET | Source: Aspargo Laboratories, Inc.

Aspargo Labs Appoints Sam Backenroth as Chief Financial Officer

NEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Aspargo Labs, Inc. (“Aspargo Labs” or the “Company”), a pharmaceutical company commercializing a highly absorbent oral suspension spray technology capable...
April 15, 2025 08:00 ET | Source: Aspargo Laboratories, Inc.

Aspargo Labs CEO to Participate in Panel Discussion at the American Urological Association Innovation Nexus Conference

NEW YORK, April 15, 2025 (GLOBE NEWSWIRE) -- Aspargo Labs, Inc. ("Aspargo Labs" or the "Company"), a Pharmaceutical and MedTech company focused on converting the world's most meaningful medications...
April 07, 2025 08:00 ET | Source: Aspargo Laboratories, Inc.

Aspargo Labs Expands Global Leadership Team

NEW YORK, April 07, 2025 (GLOBE NEWSWIRE) -- Aspargo Labs, Inc. ("Aspargo Labs" or the "Company"), a specialty pharmaceutical and MedTech company focused on converting the world's most meaningful...
February 26, 2025 08:00 ET | Source: Aspargo Laboratories, Inc.

Aspargo Labs Appoints Mario Guralnik as Chief Regulatory Officer

NEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Aspargo Labs, Inc. (“Aspargo Labs” or the “Company”), a specialty pharmaceutical and MedTech company focused on converting the world’s most meaningful...
January 27, 2025 08:00 ET | Source: Aspargo Laboratories, Inc.

Aspargo Labs Appoints Harold D. Tamayo as Chief Financial Officer

NEW YORK, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Aspargo Labs, Inc., (“Aspargo Labs” or the “Company”), a specialty pharmacy and MedTech company focused on converting the world’s most meaningful...
December 20, 2024 08:00 ET | Source: Aspargo Laboratories, Inc.

Aspargo Labs Appoints General Managers in Spain and Germany to Drive International Expansion

NEW YORK, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Aspargo Labs, Inc. (“Aspargo Labs” or the “Company”), a specialty pharmacy and MedTech company focused on reformulating the world’s most meaningful Rx and...
November 19, 2024 08:00 ET | Source: Aspargo Laboratories, Inc.

Aspargo Labs Appoints Chief Marketing Officer

NEW YORK, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Aspargo Labs, Inc. (“Aspargo Labs” or the “Company”), a specialty pharmacy and MedTech company focused on reformulating the world’s most meaningful Rx and...
December 05, 2023 08:00 ET | Source: Aspargo Laboratories, Inc.

Aspargo Laboratories Inc. Announces Completion of Dosing of All Subjects in Sildenafil Oral Suspension Bioavailability Study and Initiation of Dosing in Companion Food-Effect Study

Dosing complete for 53 subjects in Sildenafil Oral Suspension Bioavailability StudyInitiated dosing in 38 subjects in Sildenafil Oral Suspension Food-Effect StudyTop-line data from both studies...
September 19, 2023 08:00 ET | Source: Aspargo Laboratories, Inc.

Aspargo Laboratories Inc. Announces Initial Dosing of All Subjects in Bioavailability Study for Sildenafil Oral Suspension

Study will compare bioavailability of Sildenafil Oral Suspension and Viagra® tablets under fasted conditionsCompanion study will evaluate the effects of food on the bioavailability of Sildenafil Oral...
September 05, 2023 08:00 ET | Source: Aspargo Laboratories, Inc.

Aspargo Laboratories Announces IND Clearance by U.S. FDA, Enabling Launch of Bioequivalence and Food-Effect Studies for Sildenafil Oral Spray

Company plans to initiate clinical trials in September 2023 to compare Sildenafil Oral Spray to Viagra® tablets, and effect of dose administration under fasted versus fed conditionsRepresents...